Valeo Financial Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History

Valeo Financial Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$15.03 - $16.32 $1,142 - $1,240	76 Added 0.72%	10,625 $164,000
Q2 2023 Jul 14, 2023	BUY	$15.57 - $17.11 $164,247 - $180,493	10,549 New	10,549 $165,000
Q2 2021 Jul 22, 2021	SELL	$16.55 - $18.64 $25,106 - $28,276	-1,517 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$16.71 - $19.9 $13,033 - $15,521	-780 Reduced 33.96%	1,517 $28,000
Q4 2020 Feb 11, 2021	SELL	$15.39 - $18.97 $9,587 - $11,818	-623 Reduced 21.34%	2,297 $42,000
Q3 2020 Oct 28, 2020	SELL	$17.1 - $19.19 $5,369 - $6,025	-314 Reduced 9.71%	2,920 $52,000
Q2 2020 Jul 20, 2020	BUY	$14.59 - $19.5 $3,647 - $4,875	250 Added 8.38%	3,234 $58,000
Q1 2020 Apr 13, 2020	BUY	$13.02 - $20.31 $403 - $629	31 Added 1.05%	2,984 $48,000
Q3 2019 Oct 15, 2019	BUY	$16.15 - $17.99 $48 - $53	3 Added 0.1%	2,953 $51,000
Q2 2019 Jul 10, 2019	SELL	$16.58 - $20.49 $4,509 - $5,573	-272 Reduced 8.44%	2,950 $52,000
Q1 2019 Apr 12, 2019	BUY	$16.7 - $21.52 $53,807 - $69,337	3,222 New	3,222 $66,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.